Sangamo Therapeutics (SGMO) P/E (2011 - 2026)
Sangamo Therapeutics (SGMO) P/E from Mar 31, 2011 to Jul 20, 2026. The TTM Sangamo Therapeutics (SGMO) P/E is -0.23. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Sangamo Therapeutics (SGMO)
| Year | P/E | Change |
|---|---|---|
| 2026 | -0.23 | -88.71% |
| 2025 | -1.99 | +44.85% |
| 2024 | -1.38 | +177.16% |
| 2023 | -0.50 | -85.07% |
| 2022 | -3.32 | -67.09% |
| 2021 | -10.10 | -76.28% |
| 2020 | -42.58 | +94.04% |
| 2019 | -21.94 | -27.09% |
| 2018 | -30.10 | -31.11% |
| 2017 | -43.69 | +773.13% |
| 2016 | -5.00 | -84.92% |
| 2015 | -33.19 | -71.57% |
| 2014 | -116.75 | +23.62% |
| 2013 | -94.44 | +112.13% |
| 2012 | -44.52 | +194.97% |
| 2011 | -15.09 | N/A |
Comparison Sangamo Therapeutics (SGMO) P/E with competitors
Sangamo Therapeutics (SGMO) P/E is -0.23.